Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhBMP-2/CPM in closed diaphyseal tibial fractures
2006-001831-23Phase 2Completed
- Sponsor
- Wyeth
- Start
- Nov 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dibotermin alfa in tibia fracture (2 arms), sponsored by Wyeth. Primary endpoints: Fracture union, Pain-free full weight bearing and 1 more. Started Nov 2006; status: completed.
02
Drugs
dibotermin alfa
03
Conditions
tibia fracture
Beyond the preview
Go deeper on 2006-001831-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001831-23.